Abstract: An air to air heat exchanger includes a first and a second cooling air flow passage extending over a core depth of the heat exchanger. A heated air flow passage is arranged between the cooling air flow passages, and extends over a first percentage of the core depth. Thermally conductive separators are arranged between the heated air flow passage and each of the cooling air flow passages. A first structurally reinforced section is provided between the separators, and extends from a cooling air inlet face in the core depth direction over a second percentage of the core depth. A second structurally reinforced section is provided between the separators, and extends from a cooling air outlet face in the core depth direction over a third percentage of the core depth. The sum of the first, second, and third percentages is greater than 100 percent.

Abstract: The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices.

Abstract: The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices.

Abstract: An air to air heat exchanger includes a first and a second cooling air flow passage extending over a core depth of the heat exchanger. A heated air flow passage is arranged between the cooling air flow passages, and extends over a first percentage of the core depth. Thermally conductive separators are arranged between the heated air flow passage and each of the cooling air flow passages. A first structurally reinforced section is provided between the separators, and extends from a cooling air inlet face in the core depth direction over a second percentage of the core depth. A second structurally reinforced section is provided between the separators, and extends from a cooling air outlet face in the core depth direction over a third percentage of the core depth. The sum of the first, second, and third percentages is greater than 100 percent.

Abstract: An IgG1? monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.

Abstract: An IgG1? monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.

Abstract: An IgG1 ? monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.

Abstract: A system and method to analyze a proposed venture transaction. The analysis comprises any one of a merger, acquisition, joint venture, or other venture transaction. The analysis further comprises predicting information technology capabilities of an entity formed according to the proposed venture transaction.

Abstract: A compact rotary compressor unit within internal intercooling includes a rotary shaft (10) with at least one compressor wheel (14,16) mounted thereon for rotation therewith. The compressor wheel (14,16) has an inlet end (18) of relatively small diameter and a radial discharge end (20) of relatively large diameter. A nominally donut-shaped intercooling heat exchanger (42) is centered about the shaft (10) to receive compressed air from the compressor wheel and cool the same. Both the compressor wheel (14,16) and the heat exchanger (42) are confined in a housing (28).